Trends and determinants of prescription of lithium and antidepressants for bipolar disorder in a large health care system between 2017 and 2022
Lithium remains underutilized even though it is a first-line treatment for BP, especially among certain sub-groups. Antidepressants are widely used to treat BP, often without mood stabilizers despite caution by most clinical guidelines. These findings underscore the need for continued efforts to promote use of best evidence-treatments for BP and reduce disparities in their use.
Authors
- Michael Albert (ORCID: https://orcid.org/0000-0002-0239-1768)
- Catherine Steger
- Fernando S. Goes (ORCID: https://orcid.org/0000-0001-6262-8264)
- Peter P. Zandi (ORCID: https://orcid.org/0000-0001-8423-2623)
- Shreeya Raghunath
- Josina Straub (ORCID: https://orcid.org/0009-0002-9592-4208)
- Sazal Sthapit
- B Birckhead
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1016/j.jad.2025.04.006
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00